PATIENTS WITH METASTATIC CANCER OF UNKNOWN PRIMARY SITE: DIAGNOSTIC WORKUP AND THERAPEUTIC MANAGEMENT

PATIENTS WITH METASTATIC CANCER OF UNKNOWN PRIMARY SITE: DIAGNOSTIC WORKUP AND THERAPEUTIC MANAGEMENT

Blog Article

PATIENTS WITH METASTATIC CANCER OF UNKNOWN PRIMARY SITE: DIAGNOSTIC WORKUP AND THERAPEUTIC MANAGEMENT Majeed dea eyewear H Alwan FRCS, FACS, Gastrointestinal and General Surgeon, Wellington Hospital, Wellington, New Zealand Abstract Metastatic Cancer of Unknown Primary site (CUP) accounts for about 4% of all cancer patients and is therefore one of the 10 most frequent cancer diagnoses in man.It is defined as biopsy-confirmed malignancy for which the site of origin is not identified by routine workup.It is believed that CUP represents a heterogeneous group metabo 15-gauge finish nailer cordless of malignancies that have a presumably, specific biology with clinical characteristics of rapid progression and random atypical metastases.The diagnostic work-up could be variable.

Certain clinicopathological CUP entities are considered as favorable subsets responding to systemic platinum-based chemotherapy or managed by locoregional treatment.These subsets have a better prognosis than the average median survival time of four months in patients who belong to the non-favorable subsets.